N/A N=40 Randomized Double-blind Treatment

Effect of Structured Progressive Task-Oriented Circuit Class Training With Motor Imagery on Gait in Stroke

Stroke · Gait, Hemiplegic

Bottom Line

View on ClinicalTrials.gov: NCT03436810 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2021

Primary outcome: Primary: Change of Gait Speed at 4 Weeks — 0.78; 0.58 meter per second

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Motor imagery (Procedure); Health education (Procedure); Task-Oriented Circuit Class Training (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Mahidol University
Primary completion: Oct 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Change of Gait Speed at 4 Weeks	0.78; 0.58	—
PRIMARY Change of Step Length at 4 Weeks	49.76; 42.07; 47.78; 41.45	—
SECONDARY Change of Step Time at 4 Weeks	0.72; 0.83; 0.53; 0.70	—
SECONDARY Change of Cadence at 4 Weeks	94.13; 78.88	—
SECONDARY Change of 6-minute Walk Score at 4 Weeks	246.50; 152.50	—
SECONDARY Change of Number of Step at 4 Weeks	12.60; 10.65	—
SECONDARY Change of Timed Up and Go Score at 4 Weeks	11.25; 14.01	—
SECONDARY Change of Muscle Strength at 4 Weeks	3.30; 2.90; 3.30; 3.00; 3.35; 2.70	—
SECONDARY Change of Muscle Tone at 4 Weeks	1.00; 1.00; 1.00; 1.00	—

Summary

The objectives of the study will be General Objective is to investigate the effect of TOCCT with MI on gait performance in patients with stroke. Speific Objevtives. Specific Objectives are to compare the effect of TOCCT with MI and TOCCT with education on the spatio-temporal and functional gait variables in patients with stroke, to investigate the spatio-temporal and functional gait variables in patients with stroke after receiving TOCCT with MI and to investigate the spatio-temporal and functional gait variables in patients with stroke after receiving TOCCT with education.

Eligibility Criteria

Inclusion Criteria

First stroke and paresis on unilateral side of the body
Age 18 - 75 years
Post-stroke duration 3 - 12 months
Middle cerebral artery (MCA) involvement
Ability to walk at least 10 meters with or without using assistance
Functional Ambulation Category (FAC) more than or equal to 3
Mini Mental State Examination (MMSE) more than or equal to 24
National Institutes of Health Stroke Scale (NIHSS) lessor than 14
MI ability by the Kinesthetic and Visual Imagery Questionnaire (KVIQ-10) more than or equal to 3

Exclusion Criteria

Unstable cardiopulmonary problems
Other neurological conditions such as Parkinson's disease, Alzheimer's disease, or epilepsy
Orthopedic and rheumatologic disorders with weight bearing pain
Unable to communicate or unable to follow commands
Serious cardiac conditions
Patients with unilateral spatial neglect
Patients with ataxic movement

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03436810). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.